By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ardelyx Inc. 

34175 Ardenwood Boulevard
Suite 100
Fremont  California  94555  U.S.A.
Phone: 510-745-1700 Fax: n/a


Company News
Ardelyx Inc. (ARDX) Chief Scientific Officer, Dominique Charmot, Announces Retirement From The Company At Year-End 9/5/2014 9:50:39 AM
Ardelyx Inc. (ARDX) To Present At The Wedbush 2014 Life Sciences Management Access Conference 8/5/2014 9:31:07 AM
Ardelyx Inc. (ARDX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/25/2014 6:20:40 AM
Fremont Biotech Ardelyx Inc. (ARDX) Prices IPO At $14 Per Share 6/19/2014 6:12:16 AM
Bay Area's Ardelyx Inc. Lowers IPO Target Slightly, Now Hopes To Raise Up To $62 Million 6/11/2014 7:10:23 AM
Fremont-Based Ardelyx Inc. Files For $69 Million IPO 5/21/2014 8:20:45 AM
Ardelyx Inc. Receives $25 Million Milestone From AstraZeneca PLC (AZN) For Commencement Of Phase 2b Clinical Trial Of Tenapanor 5/15/2014 7:18:34 AM
Bay Area's Ardelyx Inc. Nabs Kidney Disease Pact Worth $198 Million With Pharma Giant Sanofi (France) (SAN.PA) 2/24/2014 9:20:51 AM
Ardelyx Inc. Receives $15 Million Milestone As Part of Ongoing Tenapanor Collaboration With AstraZeneca PLC (AZN) 1/13/2014 9:35:56 AM
AstraZeneca PLC (AZN) Boosts Pipeline With $272 Million Ardelyx Inc. Drug Deal 10/8/2012 7:48:11 AM